Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice
暂无分享,去创建一个
P. Calabrò | F. Gragnano | F. C. Sasso | A. Cesaro | E. Moscarella | R. Galiero | A. Caturano | E. Vetrano | V. Acerbo | G. De Michele | G. Signore | Gianmaria Scherillo | Francesco Paolo Rotolo | F. Scialla | Giuseppe Raucci | Domenico Panico | Roberto Ruggiero